SM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SM is not a good buy right now for an impatient buyer. The setup is mildly bullish (positive MACD) and sentiment is constructive (bullish options skew, positive liquidity/merger headlines), but price is pressing into nearby resistance (R1 19.83) with an elevated short-term RSI (68) and no Intellectia entry signals to justify forcing a chase. Best call: HOLD and only turn constructive on a clean break/hold above ~19.83–20.34.
Intellectia Proprietary Trading Signals
Trend/Momentum: MACD histogram is positive and expanding (bullish momentum building). RSI(6) ~68 is near overbought territory, implying limited immediate upside before a pause/pullback. Moving averages: Converging MAs suggest the stock is in a transition zone rather than a strong established trend. Levels: Pivot 19.006 (near-term anchor). Resistance at R1 19.833 then R2 20.344. Support at S1 18.179 then S2 17.668. Interpretation: With price at 19.46, upside is constrained into 19.83–20.34 unless buyers show follow-through; a pullback toward ~19.01 is plausible if momentum fades. Quant pattern read: Similar-pattern stats imply slightly negative next day/week (-0.44% / -0.61%) but positive 1-month drift (+4.24%), which aligns with “near-term chop, medium-term recovery.”
improves scale and positioning among U.S. independents.
strengthens liquidity and financial flexibility.
raises odds of a short-term stall/pullback.
Latest quarter provided: 2025/Q3. Growth: Revenue rose to $811.6M (+26.1% YoY), showing strong top-line growth. Profitability: Net income fell to $155.1M (-35.5% YoY) and EPS to $1.35 (-35.4% YoY); gross margin dropped to 31.69 (-30.2% YoY). Takeaway: growth is solid, but margins/earnings are compressing—consistent with commodity price/cost pressure and a less favorable profitability trend heading into the next report (QDEC 2025).
Recent changes are mixed but skew cautious near-term: Susquehanna (Jan 26, 2026) kept Neutral and cut PT to $19 (now essentially at/just below current price), citing oil oversupply and lower WTI assumptions. Mizuho (Jan 9, 2026) maintained Outperform but cut PT to $34 from $38, pointing to a modestly reduced activity pace. Wall Street pros: (1) scale/strategic benefits from Civitas merger, (2) improved liquidity via expanded credit facility, (3) natural gas long-term demand narrative. Wall Street cons: (1) oil price/oversupply macro pressure, (2) earnings/margin compression trend in latest quarter, (3) post-merger integration/execution risk.
